Assets
|
June
30, March
31,
|
||||||||
Current
Assets:
|
2008 2008
|
|
|||||||
Cash
and cash equivalents
|
$ | 18,181 | $ | 19,271 | |||||
Accounts
receivable, net of allowances for sales returns and doubtful accounts of
$227 and $191 at June 30, 2008 and March 31, 2008,
respectively
|
5,994 | 6,758 | |||||||
Inventories,
net
|
11,009 | 11,056 | |||||||
Prepaid
expenses and other current assets
|
794 | 788 | |||||||
Total
current assets
|
35,978 | 37,873 | |||||||
Property
and equipment, net
|
1,233 | 1,213 | |||||||
Intangible
assets, net
|
842 | 903 | |||||||
Other
assets
|
84 | 90 | |||||||
Total
assets
|
$ | 38,137 | $ | 40,079 | |||||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||||
Current
liabilities:
|
|||||||||
Notes
payable and bank lines of credit
|
$ | 8 | $ | 14 | |||||
Accounts
payable
|
896 | 1,469 | |||||||
Accrued
product warranty
|
1,315 | 1,770 | |||||||
Deferred
revenue
|
383 | 252 | |||||||
Accrued
expenses and other current liabilities
|
3,067 | 3,644 | |||||||
Total
current liabilities
|
5,669 | 7,149 | |||||||
Total
long term liabilities
|
— | — | |||||||
Total
liabilities
|
5,669 | 7,149 | |||||||
Commitments
and contingencies (Note 7)
|
|||||||||
Stockholders’
equity:
|
|||||||||
Preferred
stock; $0.01 par value; 5,000,000 shares authorized; none issued and
outstanding
|
— | — | |||||||
Common
stock; $0.01 par value; 200,000,000 shares authorized; 7,263,473 and
7,242,736 shares
issued and outstanding at June 30, 2008 and March 31, 2008,
respectively
|
73 | 72 | |||||||
Additional
paid-in capital
|
123,898 | 123,567 | |||||||
Accumulated
other comprehensive income (loss)
|
(448 | ) | (446 | ) | |||||
Accumulated
deficit
|
(91,055 | ) | (90,263 | ) | |||||
Total
stockholders’ equity
|
32,468 | 32,930 | |||||||
Total
liabilities and stockholders’ equity
|
$ | 38,137 | $ | 40,079 | |||||
Three
Months Ended
June 30,
|
|||||||||
2008
|
2007
|
||||||||
Revenue
|
$ | 4,729 | $ | 4,598 | |||||
Cost
of revenue
|
2,402 | 2,977 | |||||||
Gross
profit
|
2,327 | 1,621 | |||||||
Operating
expenses:
|
|||||||||
Research
and development expenses
|
1,136 | 778 | |||||||
Sales
and marketing expenses
|
843 | 1,006 | |||||||
General
and administrative expenses
|
1,330 | 1,203 | |||||||
Total
operating expenses
|
3,309 | 2,987 | |||||||
Operating
loss
|
(982 | ) | (1,366 | ) | |||||
Other
income (expense), net
|
190 | 728 | |||||||
Net
loss
|
$ | (792 | ) | $ | (638 | ) | |||
Net
loss per share, basic and diluted
|
$ | (0.11 | ) | $ | (0.09 | ) | |||
Shares
used in per share computation:
|
|||||||||
Basic
and diluted
|
7,177 | 7,110 |